Breast cancer as a systemic disease: a view of metastasis
about
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsMedicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016Identification of novel drugs to target dormant micrometastasesThe role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysisProtein Kinase C-ε Promotes EMT in Breast Cancer.Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancerThe prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based studyBreast cancer subtypes predict the preferential site of distant metastases: a SEER based studyMAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study.Daily application of low magnitude mechanical stimulus inhibits the growth of MDA-MB-231 breast cancer cells in vitro.First pathological study of canine primary breast lymphoma and the description of its clinicopathological characteristics as an animal model for human primary breast lymphoma.Clinicopathological significance and potential drug target of RUNX3 in breast cancer.Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticlesCigarette smoke induces cell motility via platelet-activating factor accumulation in breast cancer cells: a potential mechanism for metastatic disease.Repurposing the antipsychotic trifluoperazine as an antimetastasis agent.SEMA6D Expression and Patient Survival in Breast Invasive CarcinomaExpression of integrin-binding protein Nischarin in metastatic breast cancer.Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.Expression of HAX1 and Ki-67 in breast cancer and its correlations with patient's clinicopathological characteristics and prognosis.Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancerEphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.BREAST CANCER METASTASIS IN THE STOMACH: WHEN THE GASTRECTOMY IS INDICATED ?MicroRNA-490 inhibits tumorigenesis and progression in breast cancer.Quantitative Systems Pharmacology: A Framework for Context.The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis.STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer.Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis.Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.Patterns of distant metastasis in Chinese women according to breast cancer subtypesLiposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse ModelsAutomated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.MUC1: a novel metabolic master regulator.Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysisThe HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.Systems engineering meets quantitative systems pharmacology: from low-level targets to engaging the host defenses.Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells
P2860
Q26776113-713F1E75-37FF-4A6B-BE2B-C78391FE47E7Q26786476-6BE0E690-197D-4AC5-87DB-727C66959DA8Q28069444-FB5AEAF8-7100-450E-8724-3FD87EAACD38Q28394296-B04C7865-C09F-4B2E-BA0F-87E7B7968506Q30276213-0351C866-5D7C-42B2-9820-5152734AD290Q30413942-CE63DC99-3E40-4569-B9E8-7CF02AD2B846Q33598054-8B03E3FB-02D0-4872-932F-2CAA758B0F49Q33688668-E9557869-C83B-4C8D-82F4-5E6230F4CB23Q33709532-72B96CA8-A86C-4DEC-A445-B4C14204E08BQ34007872-D4DCFED1-424B-4D02-BB5C-3F15DD92EF6CQ34401989-0BD48613-9B40-4320-BA9F-4FE936491931Q34607482-9A0B02AA-33C6-4EF5-AC79-49644233FC1AQ34700919-13817890-354F-4B2A-B97C-939ED534F46BQ35051903-B63F5A43-3291-4706-8043-46D52E117F8BQ35105148-02DCC544-32E6-45EE-BE4B-B32E090856D5Q35363053-DEA3D515-93F1-4A8B-8E47-B00368BBEE26Q35536672-C16B3BB8-9AD8-4994-8F8F-B4FB46BA9178Q35564103-2D4BE93F-9369-4CAE-9D02-1C2973213FE3Q35628438-DE3B013E-A185-4CE3-B33C-2E7A2868496FQ35892646-F47B9B60-C497-4315-9B22-5751EEA6B11CQ35993101-2C053F89-D304-46E3-9199-7227A3808C94Q36492898-EC1A9AE1-A0C5-4C3C-B4C6-AE7FA2C04423Q36546746-2A38E988-D65A-491C-BA56-2886D02DC9B3Q37045576-223A3709-3803-4D83-9F5F-E05B111EF366Q37094566-92BDF642-FF6E-4C8D-8E44-244F1AE48B43Q37138386-E99F07B1-A247-4744-9574-9C5DC3853C03Q37200950-EF069E27-0B38-49D2-9FAB-52FAC01B6391Q37226515-035A8963-ED8C-4D69-B675-45C2FC30AC84Q37268971-64884710-6C20-4776-85C1-2B440FA11B2DQ37269072-02F0A31C-3C69-4E05-8A14-60E161B9DC76Q37421798-0180C738-6101-4169-9A45-3267D400AEC4Q37559704-9ABBCA0E-73F7-425D-A40D-6DA5C690BEAFQ37565346-45861910-7A4F-4A6B-B174-8C2B687656C8Q37668583-0DE42FC0-9393-40CA-ABC6-8C3FDFD7C1F3Q37722894-CDF93CC3-50FA-4EFC-9625-D4606674D46FQ38177983-E1163134-7BEC-44D3-9FCC-E8BD09719D6AQ38205442-3DAA0285-7463-4C14-B777-6524AE049478Q38302045-8B48D39F-9722-43D2-B25F-4C0116BEA496Q38380621-0FC953B5-E726-4552-96DF-80E8EBB41943Q38710434-002ECF0D-483A-4CFD-86D2-24A4DEADAABF
P2860
Breast cancer as a systemic disease: a view of metastasis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer as a systemic disease: a view of metastasis
@en
Breast cancer as a systemic disease: a view of metastasis.
@nl
type
label
Breast cancer as a systemic disease: a view of metastasis
@en
Breast cancer as a systemic disease: a view of metastasis.
@nl
prefLabel
Breast cancer as a systemic disease: a view of metastasis
@en
Breast cancer as a systemic disease: a view of metastasis.
@nl
P2860
P356
P1476
Breast cancer as a systemic disease: a view of metastasis
@en
P2093
S S McAllister
P2860
P304
P356
10.1111/JOIM.12084
P407
P577
2013-08-01T00:00:00Z